Human Placental Membrane Products for Foot and Leg Ulcers
(BIORESCUE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Human Placental Membrane Products
How Is the Trial Designed?
8
Treatment groups
Experimental Treatment
Tri-Membrane Wrap™ is an allograft derived from human amniotic membrane.
Tri-Membrane Wrap™ is an allograft derived from human amniotic membrane.
Membrane Wrap™ is an allograft derived from human amniotic membrane.
Membrane Wrap™ is an allograft derived from human amniotic membrane.
Membrane Wrap-Lite™ is an allograft derived from human amniotic membrane.
Membrane Wrap-Lite™ is an allograft derived from human amniotic membrane.
Membrane Wrap-Hydro™ is an allograft derived from human amniotic membrane.
Membrane Wrap-Hydro™ is an allograft derived from human amniotic membrane.
Find a Clinic Near You
Who Is Running the Clinical Trial?
BioLab Holdings
Lead Sponsor
Serena Group
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.